With this device’s U.S. commercial launch, Tandem aims to expand its durable insulin pump business and provide individuals living with diabetes unparalleled control and comfort in managing their ...

insulin pumps and continuous glucose monitoring (CGM) devices – is the first such controller that is flexible enough to be used with a range of devices, and not just those sold by Tandem ...

TNDM's shares rise as its expanding product portfolio gains market traction. However, the unfavorable macroeconomic scenario ...

Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

“So the pump can determine based on my blood sugar and carbs, how much insulin to take.” The goal of the multi-year research with UVa and funded by Tandem is to develop a fully automated ...

A spate of year-end collaborations highlights growing enthusiasm for expanding use of automated insulin delivery devices or pumps in management of type 1 diabetes only to include many patients with ...

Modular Medical develops patented insulin delivery technologies, aiming to improve access to glycemic control. Its founder, ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.